Juan Carlos Laguna
Juan Carlos Laguna is an expert in Biochemistry at Hospital Clínic de Barcelona (Spain). Juan Carlos Laguna has authored 228 publications, the most recent in 2026. SLR score: 687 (community average: 125). How the SLR is computed.
LeadR Profile
Biochemistry
Subspecialties: Oncology - Pharmacy - Hepatology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2000 - 2026
Number : 228
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Validation of the lung immune prognostic index in extensive-stage small cell lung cancer: Post hoc analysis of the caspian and IMpower133 phase 3 trials. PMID 42520592 — cells, lung, neoplasms, drug therapy, biomarkers, immunotherapy, lung neoplasms, small cell lung carcinoma, therapeutics, chemotherapy | Eur J Cancer | 2026 | 0 |
| Therapeutic Drug Monitoring and Model-Informed Precision Dosing of Oral TKIs and PARP Inhibitors: A Practical Framework for Clinical Implementation. PMID 42283932 — growth, poly(adp-ribose) polymerase inhibitors, pharmaceutical preparations, genes, abl, ribose, drug monitoring, adenosine, receptors, growth factor, pharmacology, adenosine diphosphate, therapeutics | Clin Pharmacokinet | 2026 | 0 |
| A Global Perspective on Metabolic Dysfunction-Associated Steatotic Liver Disease: From Molecular Mechanisms to Therapeutic Strategy Innovation. PMID 41754196 — liver diseases, liver, food, sex characteristics, sex, therapeutics, sex differences | Nutrients | 2026 | 0 |
| Radon risk mapping in Spain: a population and building-inclusive approach. PMID 41548338 — risk assessment, environmental health | Environ Int | 2025 | 0 |
| Germline Mutation Analysis and Real-World Impact in a Selected Cohort of Patients with Non-Small Cell Lung Cancer: INHERITY LC Study. PMID 41290502 — cells, research design, genes, lung, neoplasms, carcinoma, non-small-cell lung, germ-line mutation, lung neoplasms, small cell lung carcinoma, prevalence, genes, brca2, mutation | Clin Lung Cancer | 2025 | 0 |
LeadR Networks
Main global connection map